Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Benjamin Popokh

1PUBLICATIONS

15CO-AUTHORS

Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jul 12, 2025

Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group.

Maxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi

Pageof 1

Frequent Collaborators

1 joint publications

Alireza Ghoreifi

1 joint publications

Riccardo Autorino

1 joint publications

Gabriele Bignante

1 joint publications

Dhruv Puri

1 joint publications

Firas Abdollah

1 joint publications

Giuseppe Simone

1 joint publications

Gabriele Tuderti

1 joint publications

Ahmed Eraky

1 joint publications

Enrico N Checcucci

1 joint publications

Alessandro Antonelli

Frequent Collaborators

1 joint publications

Alireza Ghoreifi

1 joint publications

Riccardo Autorino

1 joint publications

Gabriele Bignante

1 joint publications

Dhruv Puri

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos